UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

GRP78 as a novel predictor of responsiveness to chemotherapy in breast cancer

Cancer research (Chicago, Ill.), 2006-08, Vol.66 (16), p.7849-7853

2006

Volltextzugriff (PDF)

Preoperative Twice-Weekly Paclitaxel With Concurrent Radiation Therapy Followed by Surgery and Postoperative Doxorubicin-Based Chemotherapy in Locally Advanced Breast Cancer: A Phase I/II Trial

Journal of clinical oncology, 2003-03, Vol.21 (5), p.864-870

2003

Volltextzugriff (PDF)

Reduced Mammographic Density with Use of a Gonadotropin-Releasing Hormone Agonist–Based Chemoprevention Regimen in BRCA1 Carriers

Clinical cancer research, 2007-01, Vol.13 (2), p.654-658

2007

Volltextzugriff (PDF)

Lowering oral contraceptive norethindrone dose increases estrogen and progesterone receptor levels with no reduction in proliferation of breast epithelium: a randomized trial

Contraception (Stoneham), 2012-09, Vol.86 (3), p.238-243

2012

Volltextzugriff (PDF)

Pharmacokinetic and Pharmacodynamic Evaluation of the Glycinamide Ribonucleotide Formyltransferase Inhibitor AG2034

Clinical cancer research, 2000-07, Vol.6 (7), p.2677-2684

2000

Volltextzugriff (PDF)

Reevaluation of the maximum tolerated dose of continuous venous infusion of 5-fluorouracil with pharmacokinetics

Cancer research (Chicago, Ill.), 1988-01, Vol.48 (2), p.459-461

1988

Volltextzugriff (PDF)

Problems Involved in Including Women with Simple Hysterectomy in Epidemiologic Studies Measuring the Effects of Hormone Replacement Therapy on Breast Cancer Risk

American journal of epidemiology, 1998-04, Vol.147 (8), p.718-721

1998

Volltextzugriff (PDF)

Depot leuprolide acetate with estrogen and progestin add-back for long-term treatment of premenstrual syndrome

Fertility and sterility, 1994-11, Vol.62 (5), p.932-937

1994

Volltextzugriff (PDF)

Weekly lometrexol with daily oral folic acid is appropriate for phase II evaluation

Cancer chemotherapy and pharmacology, 2000-01, Vol.45 (2), p.103-110

2000

Volltextzugriff (PDF)

Effect of valspodar on the pharmacokinetics of unbound paclitaxel

Investigational new drugs, 2003-08, Vol.21 (3), p.291-298

2003

Volltextzugriff (PDF)

Phase I and pharmacokinetic study of oral UFT, a combination of the 5-fluorouracil prodrug tegafur and uracil

Clinical cancer research, 1996-09, Vol.2 (9), p.1461-1467

1996

Volltextzugriff (PDF)

Phase I study of AG2034, a targeted GARFT inhibitor, administered once every 3 weeks

Cancer chemotherapy and pharmacology, 2000, Vol.45 (5), p.423-427

2000

Volltextzugriff (PDF)

The Prevention of Breast Cancer through Reduced Ovarian Steroid Exposure

Acta oncologica, 1992, Vol.31 (2), p.167-174

1992

Volltextzugriff (PDF)

Thymidylate synthetase inhibition in malignant tumors and normal liver of patients given intravenous 5-fluorouracil

Cancer research (Chicago, Ill.), 1984-09, Vol.44 (9), p.4144-4150

1984

Volltextzugriff (PDF)

Phase II Clinical Trial of Carboplatin, Ifosfamide, with Oral Mesna for Metastatic Breast Carcinoma

Cancer investigation, 1995, Vol.13 (2), p.160-164

1995

Volltextzugriff (PDF)

Low-dose recombinant interleukin-2 and low-dose cyclophosphamide in metastatic breast cancer

Cancer Immunology Immunotherapy, 1992-11, Vol.34 (6), p.424-426

1992

Volltextzugriff (PDF)

Tolerance of Extended (28 Day) Continuous Infusion of 5-Fluorouracil in Advanced Head and Neck Cancer

Selective Cancer Therapeutics, 1991, Vol.7 (1), p.17-21

1991

Volltextzugriff (PDF)

1 – 17 von 17

Suche als RSS-Feed

Aktive Filter

ThemaPharmacology. Drug Treatments

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(17)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(17)

Sprache

Englisch
(17)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(17)
Humans
(17)
Life Sciences & Biomedicine
(17)
Medical Sciences
(17)
Science & Technology
(17)
Female
(16)
Adult
(14)
Oncology
(14)
Antineoplastic Agents
(13)
Middle Aged
(11)
Aged
(9)
Chemotherapy
(7)
Male
(6)
Antineoplastic Agents - Therapeutic Use
(4)
Breast Neoplasms - Drug Therapy
(4)
Drug Administration Schedule
(4)
Infusions, Intravenous
(4)
Neoplasms - Drug Therapy
(4)
Administration, Oral
(3)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

GRP78 as a novel predictor of responsiveness to chemotherapy in breast cancer

Preoperative Twice-Weekly Paclitaxel With Concurrent Radiation Therapy Followed by Surgery and Postoperative Doxorubicin-Based Chemotherapy in Locally Advanced Breast Cancer: A Phase I/II Trial

Reduced Mammographic Density with Use of a Gonadotropin-Releasing Hormone Agonist–Based Chemoprevention Regimen in BRCA1 Carriers

Lowering oral contraceptive norethindrone dose increases estrogen and progesterone receptor levels with no reduction in proliferation of breast epithelium: a randomized trial

Pharmacokinetic and Pharmacodynamic Evaluation of the Glycinamide Ribonucleotide Formyltransferase Inhibitor AG2034

Reevaluation of the maximum tolerated dose of continuous venous infusion of 5-fluorouracil with pharmacokinetics

Problems Involved in Including Women with Simple Hysterectomy in Epidemiologic Studies Measuring the Effects of Hormone Replacement Therapy on Breast Cancer Risk

Depot leuprolide acetate with estrogen and progestin add-back for long-term treatment of premenstrual syndrome

Weekly lometrexol with daily oral folic acid is appropriate for phase II evaluation

Effect of valspodar on the pharmacokinetics of unbound paclitaxel

Phase I and pharmacokinetic study of oral UFT, a combination of the 5-fluorouracil prodrug tegafur and uracil

Phase I study of AG2034, a targeted GARFT inhibitor, administered once every 3 weeks

The Prevention of Breast Cancer through Reduced Ovarian Steroid Exposure

Thymidylate synthetase inhibition in malignant tumors and normal liver of patients given intravenous 5-fluorouracil

Phase II Clinical Trial of Carboplatin, Ifosfamide, with Oral Mesna for Metastatic Breast Carcinoma

Low-dose recombinant interleukin-2 and low-dose cyclophosphamide in metastatic breast cancer

Tolerance of Extended (28 Day) Continuous Infusion of 5-Fluorouracil in Advanced Head and Neck Cancer

Aktive Filter

Suchergebnisse filtern